Dr Michael Lamprecht
Michael Lamprecht is an Investment Associate at Tenmile, based in Sydney, specializing in biotechnology, startups, and early-stage investments. With over 15 years in the field, he has a unique background in developing regulatory and clinical strategies for novel cell-based therapies. His previous roles include Entrepreneur-in-Residence at Xora Innovation, Singapore, and Director of Regulatory Affairs at EpiBone, a U.S. biotech firm pioneering adult stem cell-based bone and cartilage grafts. Dr. Lamprecht holds a PhD in biomedical engineering from Columbia University, along with a bachelor’s degree in biomedical engineering from Boston University.